Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE-Reference-Cited by-同舟云学术

Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE

Published:2010-09 Issue:3 Volume:126 Page:222-226
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Rodger M.A.,Le Gal G.,Carrier Marc,Betancourt M.T.,Kahn S.R.,Wells P.S.,Anderson D.A.,Lacut K.,Chagnon I.,Solymoss S.,Crowther M.,Perrier A.,White R.,Vickars L.,Ramsay T.,Kovacs M.J.

Publisher

Elsevier BV

Subject

Hematology

Reference35 articles.

1. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester study;Anderson;Arch Intern Med,1991

2. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study;Silverstein;Arch Intern Med,1998

3. The epidemiology of venous thromboembolism;White;Circulation,2003

4. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators;Agnelli;N Engl J Med,2001

5. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism;Kearon;N Engl J Med,1999

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19;Research and Practice in Thrombosis and Haemostasis;2023-08

2. Thrombophilia Testing - a Systematic Review;Clinical Laboratory;2023

3. Thrombosis, Inflammation, and Lipoprotein(a): Clinical Implications;Contemporary Cardiology;2023

4. Osteonecrosis of the Femoral Head in Patients with Hypercoagulability—From Pathophysiology to Therapeutic Implications;International Journal of Molecular Sciences;2021-06-24

5. Lifestyle Moderates Genetic Risk of Venous Thromboembolism;Arteriosclerosis, Thrombosis, and Vascular Biology;2020-11